Diagnos Stock Shares Owned By Institutions
ADK Stock | CAD 0.31 0.01 3.13% |
Diagnos fundamentals help investors to digest information that contributes to Diagnos' financial success or failures. It also enables traders to predict the movement of Diagnos Stock. The fundamental analysis module provides a way to measure Diagnos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Diagnos stock.
Diagnos | Shares Owned By Institutions |
Diagnos Company Shares Owned By Institutions Analysis
Diagnos' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Diagnos Shares Owned By Institutions | 0.01 % |
Most of Diagnos' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diagnos is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Diagnos Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for Diagnos is extremely important. It helps to project a fair market value of Diagnos Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Diagnos' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Diagnos' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Diagnos' interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 0.01% of Diagnos are shares owned by institutions. This is 99.98% lower than that of the Health Care Technology sector and 99.98% lower than that of the Health Care industry. The shares owned by institutions for all Canada stocks is 99.97% higher than that of the company.
Diagnos Current Valuation Drivers
We derive many important indicators used in calculating different scores of Diagnos from analyzing Diagnos' financial statements. These drivers represent accounts that assess Diagnos' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Diagnos' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 8.1M | 34.1M | 17.2M | 24.4M | 20.0M | 21.0M | |
Enterprise Value | 13.5M | 33.8M | 17.3M | 25.1M | 23.0M | 24.1M |
Diagnos Fundamentals
Return On Equity | -24.52 | ||||
Return On Asset | -1.34 | ||||
Operating Margin | (15.76) % | ||||
Current Valuation | 30.21 M | ||||
Shares Outstanding | 95 M | ||||
Shares Owned By Insiders | 14.41 % | ||||
Shares Owned By Institutions | 0.01 % | ||||
Number Of Shares Shorted | 66.56 K | ||||
Price To Earning | (2.76) X | ||||
Price To Book | 54.61 X | ||||
Price To Sales | 180.09 X | ||||
Revenue | 170.16 K | ||||
Gross Profit | (306.77 K) | ||||
EBITDA | (2.48 M) | ||||
Net Income | (3.12 M) | ||||
Cash And Equivalents | 97.5 K | ||||
Total Debt | 3.19 M | ||||
Debt To Equity | 2.12 % | ||||
Current Ratio | 1.19 X | ||||
Book Value Per Share | (0.04) X | ||||
Cash Flow From Operations | (2.41 M) | ||||
Short Ratio | 0.06 X | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 1.5 | ||||
Beta | -0.46 | ||||
Market Capitalization | 29.45 M | ||||
Total Asset | 663.79 K | ||||
Retained Earnings | (50.65 M) | ||||
Working Capital | (1.22 M) | ||||
Net Asset | 663.79 K |
About Diagnos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diagnos's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diagnos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diagnos based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.